Phase I study of gemcitabine (GEM) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Kawabata, S [1 ]
Oka, M [1 ]
Fukuda, M [1 ]
Kinoshita, A [1 ]
Fukuda, M [1 ]
Nagashima, S [1 ]
Nakamura, Y [1 ]
Nakano, H [1 ]
Soda, H [1 ]
Kohno, S [1 ]
机构：
[1] Nagasaki Univ, Nagasaki 852, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7291
引用
收藏
页码：688S / 688S
页数：1
相关论文
共 50 条
  • [21] A Phase I Study of Gemcitabine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2
    Kim, Young Hak
    Kubota, Kaoru
    Goto, Koichi
    Yoh, Kiyotaka
    Niho, Seiji
    Ohmatsu, Hironobu
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (09) : 576 - 581
  • [22] A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC).
    Mancuso, A
    Migliorino, MR
    Martelli, O
    Belli, R
    Di Molfetta, M
    De Petris, L
    Di Salvia, R
    De Marinis, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [23] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [24] Gemcitabine(GEM) in advanced non small cell lung cancer (NSCLC) of elderly. A phase II study
    Pasquini, E
    Tassinari, D
    Nicolini, M
    Gianni, L
    Oliverio, G
    Tononi, A
    Papi, M
    Drudi, G
    Panzini, I
    Ravaioll, A
    ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
  • [25] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    LUNG CANCER, 2005, 49 : S242 - S242
  • [26] A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small-cell lung cancer (NSCLC) (final report).
    Hasegawa, Y
    Takanashi, S
    Nakagawa, H
    Okudera, K
    Hayashi, A
    Morimoto, T
    Taima, K
    Okumura, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 703S - 703S
  • [27] Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer
    Dómine, M
    Casado, V
    Estévez, LG
    León, A
    Martin, JI
    Castillo, M
    Rubio, G
    Lobo, F
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 4 - 9
  • [28] A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)
    Jordi Rodon
    Charlotte D. Jacobs
    Quincy Chu
    Eric K. Rowinsky
    Arturo Lopez-Anaya
    Chris H. Takimoto
    Heather A. Wakelee
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 825 - 834
  • [29] Phase I/II trial of docetaxel (D) and Carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Giannakakis, T
    Papadouris, S
    Kourousis, C
    Kalbakis, NK
    Tzianni, V
    Lidaki, E
    Androulakis, N
    Souklakos, J
    Sarra, E
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 94
  • [30] Phase I/II study of exisulind and gemcitabine in patients with recurrent advanced non-small cell lung cancer (NSCLC).
    Hoang, T
    Kim, K
    Merchant, J
    Traynor, AM
    Ahuja, HG
    Masters, GA
    McGovern, JD
    Oettel, KR
    Sanchez, FA
    Schiller, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 642S - 642S
12345